Cagrilintide is a long-acting analog of amylin, a hormone co-secreted with insulin by the pancreas. It has been developed to aid in weight management and glycemic control.

Actions of Cagrilintide:

1. Appetite Suppression: Cagrilintide interacts with the central nervous system to reduce appetite, leading to decreased food intake.
   
2. Delayed Gastric Emptying: It slows the rate at which the stomach empties, promoting a feeling of fullness and aiding in weight loss.
   
3. Glucagon Secretion Modulation: Cagrilintide helps regulate glucagon secretion, contributing to better blood glucose c
   

Benefits of Cagrilintide:

• Weight Loss: Clinical trials have demonstrated that cagrilintide leads to significa
  
• Enhanced Glycemic Control: By improving insulin sensitivity and glycemic control, cagrilintide offers additional benefits for patients with type 2 diabetes. ​
  
• Combination Therapy Potential: When combined with GLP-1 receptor agonists like semaglutide, cagrilintide has shown enhanced effects on weight loss and glycemic control.
  

Overall, cagrilintide represents a promising advancement in the treatment of obesity and related metabolic disorders. Its unique mechanism of action offers a multifaceted approach to weight management and glycemic control.